Trial NCT02225574

View at ClinicalTrials.gov 
Org. Study IDs: 2014-0128
Secondary IDs: NCI-2015-00044

Last trial update was posted on 2020-02-12

MeSH Interventions

Nilotinib

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid

Other Conditions


Stopping Reasons

Slow Accrual - Only 1 patient enrolled in Phase 1 - Study never went to Phase II

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID